Helminthiasis Clinical Trial
Official title:
Community-based Approach for the Management of Soil-transmitted Helminthiasis in General and Strongyloidiasis in Particular in a Highly Endemic Area
The general purpose of the project is to analyse soil-transmitted helminthiases (STH) in a highly endemic area in northern Argentina with a multidisciplinary approach. The specific objectives are to evaluate the local epidemiology of STH, validate a new diagnostic serology method for S. stercoralis and evaluate the efficacy and safety of a mass drug administration regimen with albendazole and ivermectin.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04041453 -
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03014167 -
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
|
Phase 3 | |
| Completed |
NCT02385058 -
Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population
|
Phase 4 | |
| Withdrawn |
NCT02636803 -
Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults
|
Phase 2 | |
| Completed |
NCT02725255 -
Design and Clinical Evaluation of a School Meal With Deworming Properties
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT04227834 -
Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education
|
N/A | |
| Completed |
NCT03173742 -
Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)
|
Phase 1 | |
| Completed |
NCT02397772 -
Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya
|
Phase 4 | |
| Completed |
NCT00130910 -
Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation
|
N/A | |
| Completed |
NCT00004996 -
Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections
|
||
| Recruiting |
NCT00001230 -
Host Response to Infection and Treatment in Filarial Diseases
|
||
| Completed |
NCT04041427 -
Urine Albendazole Levels for Coverage Assessment
|
N/A | |
| Completed |
NCT02396407 -
Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health
|
N/A | |
| Terminated |
NCT01271049 -
An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths
|
N/A | |
| Terminated |
NCT00817713 -
Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
|
N/A | |
| Completed |
NCT02362932 -
The Effect of an Urban Sanitation Intervention on Child Health
|
N/A | |
| Completed |
NCT02420574 -
Assessment of Drug Efficacy of Local Albendazole
|
N/A | |
| Completed |
NCT00507221 -
Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression
|
N/A | |
| Completed |
NCT00469495 -
Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
|
N/A | |
| Recruiting |
NCT01459146 -
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana
|
Phase 4 |